Over the past three years, nearly 41,000 school-going children in Karnataka have been diagnosed with congenital heart diseases (CHD), yet less than half have received treatment. These cases were identified through the Rashtriya Bal Swasthya Karyakram (RBSK) screening program, which detects heart development issues before birth, reports Deccan Herald. Identified children are referred to tertiary care centres and treated under the Ayushman Bharat-Arogya Karnataka scheme, but tracking each case on the ground remains challenging. To improve follow-up, the state plans to integrate pregnancy anomaly scans with newborn check-ups, making it easier for paediatricians to monitor heart conditions detected during prenatal ultrasounds. Once implemented, newborns flagged as high-risk due to CHD will receive closer medical attention. Experts emphasize the life-saving potential of early detection. While heart screening at birth is inconsistently practised in India, parental awareness is rising, with many requesting scans during pregnancy. Timely diagnosis and treatment can enable children with CHD to lead almost normal lives, spotlighting the importance of expanding cardiac screening programs across hospitals.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!